Global Immunotherapeutic Drugs Market Size, Status and Forecast 2020-2026

Published Date : 2020-01-27

Category : Pharma & Healthcare

No. of Pages : 98

This report focuses on the global Immunotherapeutic Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immunotherapeutic Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb

Market segment by Type, the product can be split into
Monoclonal Antibody
Vaccines
Checkpoint Inhibitor
Interferon
Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Immunotherapeutic Drugs status, future forecast, growth opportunity, key market and key players.
To present the Immunotherapeutic Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Immunotherapeutic Drugs are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immunotherapeutic Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibody
1.4.3 Vaccines
1.4.4 Checkpoint Inhibitor
1.4.5 Interferon
1.5 Market by Application
1.5.1 Global Immunotherapeutic Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 Immunotherapeutic Drugs Market Perspective (2015-2026)
2.2 Immunotherapeutic Drugs Growth Trends by Regions
2.2.1 Immunotherapeutic Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immunotherapeutic Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Immunotherapeutic Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Immunotherapeutic Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Immunotherapeutic Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Immunotherapeutic Drugs Players by Market Size
3.1.1 Global Top Immunotherapeutic Drugs Players by Revenue (2015-2020)
3.1.2 Global Immunotherapeutic Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Immunotherapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Immunotherapeutic Drugs Market Concentration Ratio
3.2.1 Global Immunotherapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Immunotherapeutic Drugs Revenue in 2019
3.3 Immunotherapeutic Drugs Key Players Head office and Area Served
3.4 Key Players Immunotherapeutic Drugs Product Solution and Service
3.5 Date of Enter into Immunotherapeutic Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Immunotherapeutic Drugs Historic Market Size by Type (2015-2020)
4.2 Global Immunotherapeutic Drugs Forecasted Market Size by Type (2021-2026)

5 Immunotherapeutic Drugs Breakdown Data by Application (2015-2026)
5.1 Global Immunotherapeutic Drugs Market Size by Application (2015-2020)
5.2 Global Immunotherapeutic Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Immunotherapeutic Drugs Market Size (2015-2020)
6.2 Immunotherapeutic Drugs Key Players in North America (2019-2020)
6.3 North America Immunotherapeutic Drugs Market Size by Type (2015-2020)
6.4 North America Immunotherapeutic Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe Immunotherapeutic Drugs Market Size (2015-2020)
7.2 Immunotherapeutic Drugs Key Players in Europe (2019-2020)
7.3 Europe Immunotherapeutic Drugs Market Size by Type (2015-2020)
7.4 Europe Immunotherapeutic Drugs Market Size by Application (2015-2020)

8 China
8.1 China Immunotherapeutic Drugs Market Size (2015-2020)
8.2 Immunotherapeutic Drugs Key Players in China (2019-2020)
8.3 China Immunotherapeutic Drugs Market Size by Type (2015-2020)
8.4 China Immunotherapeutic Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan Immunotherapeutic Drugs Market Size (2015-2020)
9.2 Immunotherapeutic Drugs Key Players in Japan (2019-2020)
9.3 Japan Immunotherapeutic Drugs Market Size by Type (2015-2020)
9.4 Japan Immunotherapeutic Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Immunotherapeutic Drugs Market Size (2015-2020)
10.2 Immunotherapeutic Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Immunotherapeutic Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Immunotherapeutic Drugs Market Size by Application (2015-2020)

11 India
11.1 India Immunotherapeutic Drugs Market Size (2015-2020)
11.2 Immunotherapeutic Drugs Key Players in India (2019-2020)
11.3 India Immunotherapeutic Drugs Market Size by Type (2015-2020)
11.4 India Immunotherapeutic Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Immunotherapeutic Drugs Market Size (2015-2020)
12.2 Immunotherapeutic Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Immunotherapeutic Drugs Market Size by Type (2015-2020)
12.4 Central & South America Immunotherapeutic Drugs Market Size by Application (2015-2020)

13Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview and Its Total Revenue
13.1.3 Roche Immunotherapeutic Drugs Introduction
13.1.4 Roche Revenue in Immunotherapeutic Drugs Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview and Its Total Revenue
13.2.3 Merck Immunotherapeutic Drugs Introduction
13.2.4 Merck Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview and Its Total Revenue
13.3.3 Novartis Immunotherapeutic Drugs Introduction
13.3.4 Novartis Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview and Its Total Revenue
13.4.3 Johnson & Johnson Immunotherapeutic Drugs Introduction
13.4.4 Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.5.3 GlaxoSmithKline Immunotherapeutic Drugs Introduction
13.5.4 GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 AbbVie
13.6.1 AbbVie Company Details
13.6.2 AbbVie Business Overview and Its Total Revenue
13.6.3 AbbVie Immunotherapeutic Drugs Introduction
13.6.4 AbbVie Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.6.5 AbbVie Recent Development
13.7 ELI Lilly
13.7.1 ELI Lilly Company Details
13.7.2 ELI Lilly Business Overview and Its Total Revenue
13.7.3 ELI Lilly Immunotherapeutic Drugs Introduction
13.7.4 ELI Lilly Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.7.5 ELI Lilly Recent Development
13.8 Amgen
13.8.1 Amgen Company Details
13.8.2 Amgen Business Overview and Its Total Revenue
13.8.3 Amgen Immunotherapeutic Drugs Introduction
13.8.4 Amgen Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.8.5 Amgen Recent Development
13.9 AstraZeneca
13.9.1 AstraZeneca Company Details
13.9.2 AstraZeneca Business Overview and Its Total Revenue
13.9.3 AstraZeneca Immunotherapeutic Drugs Introduction
13.9.4 AstraZeneca Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.9.5 AstraZeneca Recent Development
13.10 Bristol-Mysers Squibb
13.10.1 Bristol-Mysers Squibb Company Details
13.10.2 Bristol-Mysers Squibb Business Overview and Its Total Revenue
13.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Introduction
13.10.4 Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.10.5 Bristol-Mysers Squibb Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details


List of Tables

Table 1. Immunotherapeutic Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Immunotherapeutic Drugs Revenue
Table 3. Ranking of Global Top Immunotherapeutic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Immunotherapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibody
Table 6. Key Players of Vaccines
Table 7. Key Players of Checkpoint Inhibitor
Table 8. Key Players of Interferon
Table 9. Global Immunotherapeutic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Immunotherapeutic Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Immunotherapeutic Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Immunotherapeutic Drugs Market Share by Regions (2015-2020)
Table 13. Global Immunotherapeutic Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Immunotherapeutic Drugs Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Immunotherapeutic Drugs Market Growth Strategy
Table 19. Main Points Interviewed from Key Immunotherapeutic Drugs Players
Table 20. Global Immunotherapeutic Drugs Revenue by Players (2015-2020) (Million US$)
Table 21. Global Immunotherapeutic Drugs Market Share by Players (2015-2020)
Table 22. Global Top Immunotherapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunotherapeutic Drugs as of 2019)
Table 23. Global Immunotherapeutic Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Immunotherapeutic Drugs Product Solution and Service
Table 26. Date of Enter into Immunotherapeutic Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 29. Global Immunotherapeutic Drugs Market Size Share by Type (2015-2020)
Table 30. Global Immunotherapeutic Drugs Revenue Market Share by Type (2021-2026)
Table 31. Global Immunotherapeutic Drugs Market Size Share by Application (2015-2020)
Table 32. Global Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 33. Global Immunotherapeutic Drugs Market Size Share by Application (2021-2026)
Table 34. North America Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 36. North America Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 37. North America Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 38. North America Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 39. North America Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 40. Europe Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 42. Europe Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 44. Europe Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 46. China Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 47. China Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 48. China Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 49. China Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 50. China Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 51. China Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 52. Japan Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 54. Japan Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 56. Japan Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 60. Southeast Asia Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 62. Southeast Asia Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 64. India Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 65. India Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 66. India Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 67. India Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 68. India Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 69. India Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 72. Central & South America Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 74. Central & South America Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Product
Table 79. Roche Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 80. Roche Recent Development
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Product
Table 84. Merck Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 85. Merck Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. Johnson & Johnson Company Details
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Product
Table 94. Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 95. Johnson & Johnson Recent Development
Table 96. GlaxoSmithKline Company Details
Table 97. GlaxoSmithKline Business Overview
Table 98. GlaxoSmithKline Product
Table 99. GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 100. GlaxoSmithKline Recent Development
Table 101. AbbVie Company Details
Table 102. AbbVie Business Overview
Table 103. AbbVie Product
Table 104. AbbVie Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 105. AbbVie Recent Development
Table 106. ELI Lilly Company Details
Table 107. ELI Lilly Business Overview
Table 108. ELI Lilly Product
Table 109. ELI Lilly Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 110. ELI Lilly Recent Development
Table 111. Amgen Business Overview
Table 112. Amgen Product
Table 113. Amgen Company Details
Table 114. Amgen Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 115. Amgen Recent Development
Table 116. AstraZeneca Company Details
Table 117. AstraZeneca Business Overview
Table 118. AstraZeneca Product
Table 119. AstraZeneca Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 120. AstraZeneca Recent Development
Table 121. Bristol-Mysers Squibb Company Details
Table 122. Bristol-Mysers Squibb Business Overview
Table 123. Bristol-Mysers Squibb Product
Table 124. Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 125. Bristol-Mysers Squibb Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunotherapeutic Drugs Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibody Features
Figure 3. Vaccines Features
Figure 4. Checkpoint Inhibitor Features
Figure 5. Interferon Features
Figure 6. Global Immunotherapeutic Drugs Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Other Case Studies
Figure 10. Immunotherapeutic Drugs Report Years Considered
Figure 11. Global Immunotherapeutic Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Immunotherapeutic Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Immunotherapeutic Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Immunotherapeutic Drugs Market Share by Players in 2019
Figure 16. Global Top Immunotherapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunotherapeutic Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Immunotherapeutic Drugs Revenue in 2019
Figure 18. North America Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Roche Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 27. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Merck Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 29. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 31. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Johnson & Johnson Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 33. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. GlaxoSmithKline Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 35. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AbbVie Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 37. ELI Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. ELI Lilly Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 39. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Amgen Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 41. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. AstraZeneca Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 43. Bristol-Mysers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Bristol-Mysers Squibb Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed

Immunotherapeutic Drugs  Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-213-4282

sales@researchreportcenter.com